-
Drug Design, Development and Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Surface activity of surfactant spiked with vitamin A
Original Research
(2109) Views (644) Full article downloads
Authors: Vadim Bronshtein, Vugranam Venkatesh, Jas Aulakh, Philippe Chessex
Published Date August 2008
Volume 2008:2 Pages 145 - 150
DOI: http://dx.doi.org/10.2147/DDDT.S3255
Vadim Bronshtein, Vugranam Venkatesh, Jas Aulakh, Philippe Chessex
Division of Neonatology, Children’s and Women’s Health Centre of British Columbia, University of British Columbia, Vancouver, BC, Canada
Background: Intramuscular injections of vitamin A decrease the risk of broncho-pulmonary dysplasia. Admixture of vitamin A with surfactant as a lipophilic vehicle might be a less invasive modality.
Aim: Test physical properties of surfactant + vitamin A.
Methods: Miscibility and surface activity were tested in surfactant supplemented with retinyl-acetate, -palmitate, 13-cis-, or all-trans-retinoic acid.
Results: Retinol acetate (5000 IU/mL) demonstrated miscibility with surfactant when premixing with ethanol. Its surface activity was 40% lower compared to surfactant alone.
Conclusion: These findings warrant preclinical studies to test whether administration of vitamin A in subjects requiring surfactant is associated with beneficial functional properties.
Keywords: drug delivery, vitamin A, surfactant, surface tension
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Tenofovir-associated bone density loss
- The benefits and risks of testosterone replacement therapy: a review
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses




